Liberty Health Sciences (OTCMKTS:LHSIF) Stock Price Down 2.2% – Time to Sell?

Liberty Health Sciences Inc. (OTCMKTS:LHSIF)’s stock price fell 2.2% during trading on Tuesday. The company traded as low as $1.10 and last traded at $1.1446. Approximately 671,400 shares changed hands during mid-day trading, a decline of 60% from the average daily volume of 1,668,884 shares. The stock had previously closed at $1.17.

Liberty Health Sciences Stock Down 2.2%

The company has a market cap of $392.01 million, a price-to-earnings ratio of 38.17 and a beta of 1.70. The company’s fifty day moving average price is $1.14 and its two-hundred day moving average price is $1.14.

Liberty Health Sciences Company Profile

Liberty Health Sciences Inc was a Canadian cannabis company focused on cultivating, processing, and dispensing medical cannabis in the United States. Its operations were concentrated in Florida, where the company served registered medical marijuana patients through a network of dispensaries and related cannabis products.

The company’s activities included the production of cannabis flower, oils, capsules, concentrates, and other medical cannabis formulations. Liberty marketed products under its own brand and operated retail locations designed to provide patients with medical cannabis products and educational support.

Liberty Health Sciences was acquired by AYR Wellness Inc in 2021 and subsequently became part of AYR’s Florida operations.